{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:26:22Z","timestamp":1772191582358,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1124\/jpet.123.002014","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T19:00:19Z","timestamp":1716318019000},"page":"310-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comments on: Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice"],"prefix":"10.1016","volume":"389","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-6125","authenticated-orcid":false,"given":"Jon J.","family":"Brudvig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Tuske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.002014_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.123.001593","article-title":"Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice","volume":"387","author":"Anding","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002014_bib4","series-title":"Food and Drug Administration (FDA)","year":"2023"},{"key":"10.1124\/jpet.123.002014_bib5","series-title":"European Public Assessment Report \u2013 Opfolda","year":"2023"},{"key":"10.1124\/jpet.123.002014_bib6","doi-asserted-by":"crossref","unstructured":"Johnson FK, Kang J, Mondick J, Sitaraman Das S, Wasfi Y, Goldman M, Castelli J, Do HV (2022) Mechanism of action, plasma total GAA protein PK profiles, and PK\/PD relationships differ between cipaglucosidase alfa\/miglustat and alglucosidase alfa in patients with late-onset Pompe disease, in 18th Annual WORLD Symposium, San Diego, CA.","DOI":"10.1016\/j.ymgme.2021.11.158"},{"key":"10.1124\/jpet.123.002014_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040776","article-title":"The pharmacological chaperone AT2220 increases recombinant human acid \u03b1-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease","volume":"7","author":"Khanna","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.002014_bib8","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1074\/jbc.M404008200","article-title":"Lysosomal acid alpha-glucosidase consists of four different peptides processed from a single chain precursor","volume":"280","author":"Moreland","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.002014_bib9","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/mt.2014.138","article-title":"A chaperone enhances blood \u03b1-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy","volume":"22","author":"Parenti","year":"2014","journal-title":"Mol Ther"},{"key":"10.1124\/jpet.123.002014_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100769","article-title":"Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase","volume":"296","author":"Selvan","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.002014_bib11","unstructured":"Selvan N, Venkateswaran S, Feng J, Hung F, Madrid M, Mehta N, Graziano M, Brignol N, McAnany Y, Khanna R, et-al. (2021b) Enhancing delivery of acid alpha-glucosidase (GAA) to skeletal muscle in Pompe disease (PD): Key challenges and attributes of AT-GAA., in Muscular Dystrophy Association (MDA) Clinical & Scientific Congress, Virtual."},{"key":"10.1124\/jpet.123.002014_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125358","article-title":"Improved efficacy of a next-generation ERT in murine Pompe disease","volume":"4","author":"Xu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1124\/jpet.123.002014_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/bc1005416","article-title":"Strategies for Neoglycan conjugation to human acid \u03b1-glucosidase","volume":"22","author":"Zhou","year":"2011","journal-title":"Bioconjug Chem"}],"updated-by":[{"DOI":"10.1124\/jpet.123.002014err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524172588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524172588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.002014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:19:03Z","timestamp":1739978343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524172588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022356524172588"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.002014","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.123.002014err","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comments on: Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.002014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}